The rubella, which is commonly known as German measles, is a highly contagious viral infection, and particularly serious for pregnant women, since it can lead to spontaneous abortion, fetal death or a variety of weakening birth defects. Safe and profitable vaccines have made it highly preventable.
“Nepal’s success reflects the unwavering commitment of his leadershippersistent efforts of health workers and volunteers, and the inextracent support to the communities committed and informed, for a healthy beginning for babies and a future free of rubella disease, ”said Catharina Boehme, an officer in charge of the WHO in Southeast Asia.
National Immunization impulse
Nepal introduced rubella vaccines through a 2012 immunization program, starting with a national campaign aimed at children from nine months to 15 years, with a second dose added to routine schedule in 2016.
Despite the main public health emergencies, such as the earthquakes of the COVID-19 pandemic and devastating in 2015 and 2023, Nepal achieved a coverage of more than 95 percent of at least one dose of rubella vaccine in early 2024.
This Monday, the WHO regional verification commission for measles elimination and rubella made the official announcement: “This public health achievement is the result of close collaboration between the government, dedicated health workers, partners and communities.“Dr. Rajash Sambhajirao Pandav, who representative of Nepal, said.
Innovative approach
Strategies such as promoting the “month of immunization”, reaching the C notes
Hildren and efforts for districts to declare completely immunized gave a new impulse to elimination efforts.
In addition, for greater surveillance of rubella, Nepal recently introduced a robust laboratory test algorithm, the first country in the southeast region of Asia in doing so.
